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Abstract
Background: Congenital heart defects (CHDs) are a significant cause of death in infancy. Although contemporary
management ensures that 80% of affected children reach adulthood, post-infant mortality and factors associated with
death during childhood are not well-characterised. Using data from a UK-wide multicentre birth cohort of children with
serious CHDs, we observed survival and investigated independent predictors of mortality up to age 15 years.
Methods: Data were extracted retrospectively from hospital records and death certificates of 3,897 children (57% boys) in a
prospectively identified cohort, born 1992–1995 with CHDs requiring intervention or resulting in death before age one year.
A discrete-time survival model accounted for time-varying predictors; hazards ratios were estimated for mortality.
Incomplete data were addressed through multilevel multiple imputation.
Findings: By age 15 years, 932 children had died; 144 died without any procedure. Survival to one year was 79.8% (95%
confidence intervals [CI] 78.5, 81.1%) and to 15 years was 71.7% (63.9, 73.4%), with variation by cardiac diagnosis.
Importantly, 20% of cohort deaths occurred after age one year. Models using imputed data (including all children from
birth) demonstrated higher mortality risk as independently associated with cardiac diagnosis, female sex, preterm birth,
having additional cardiac defects or non-cardiac malformations. In models excluding children who had no procedure,
additional predictors of higher mortality were younger age at first procedure, lower weight or height, longer
cardiopulmonary bypass or circulatory arrest duration, and peri-procedural complications; non-cardiac malformations
were no longer significant.
Interpretation: We confirm the high mortality risk associated with CHDs in the first year of life and demonstrate an
important persisting risk of death throughout childhood. Late mortality may be underestimated by procedure-based audit
focusing on shorter-term surgical outcomes. National monitoring systems should emphasise the importance of routinely
capturing longer-term survival and exploring the mechanisms of mortality risk in children with serious CHDs.
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Introduction
Serious congenital heart defects (CHDs), requiring surgery in
the first year of life, affect around 1% of births each year in the
UK [1–3] and include a broad spectrum of complexity and
severity. Without intervention in early life, serious CHDs are often
incompatible with long-term survival. Continuous improvement in
medical, intensive care and surgical technologies have significantly
reduced infant mortality and around 80% of affected babies now
survive the first year of life [4–7]. Despite the rising number of
paediatric cardiac procedures being undertaken [8], surgical
mortality is decreasing and the number of UK adults with CHDs
is steadily growing [9]. Nevertheless, long-term survival for
individuals within most CHD subgroups remains below that of
the unaffected population [10].
Recognising the growing population of adolescents and adults
with CHDs, recent research has focused on the epidemiology and
health experience of adult survivors. It is generally assumed that
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additional mortality between infancy and 15 years of age is
extremely low and likely to be related to further surgery, yet
observational studies with prospective long-term follow-up of the
transition of children with CHDs from infancy through school,
adolescence and into adulthood are lacking. While short-term
surgical outcome studies provide extensive detail about post-
operative survival and mortality, particularly within specific CHD
subgroups, the factors associated with mortality risk that are
common to all diagnostic subgroups and their significance at
different ages are poorly defined [11]. Developing a life course
approach [12] to children and adults surviving with CHDs is a
vital step in recognising that they experience complex interactions
between intrinsic early life factors, cardiac diagnosis and the
pressures of the external environment, which have a significant
impact on their growth, development and late outcomes. There
remains a crucial lack in our understanding of the relevance of
different risk factors and exposures at each stage of the lifecourse
and how these may modify long-term outcomes, not only when
they occur in relation to critical periods but also when experienced
as repeated exposures such as multiple surgical interventions. Such
information is key to future interventions to improve survival and
health outcomes and ensure a smooth transition to adult life for
affected children.
The UK Collaborative Study of Congenital Heart Defects
(UKCSCHD) was established as a UK-wide multi-centre cohort
involving almost 4000 children, diagnosed with serious CHDs
during their first year of life, to determine prospectively survival,
health, educational and quality of life outcomes. In this paper we
examine survival from birth to 15 years of age, characterise the
timing and causes of death during childhood and investigate the
relative importance of patient-specific and early life factors to
mortality risk during childhood for this national cohort that is
largely representative of contemporary surgical and medical
management.
Materials and Methods
Ethics statement
Ethics approval was granted by Trent Multicentre Research
Ethics Committee (MREC 04/4/017). Case notes review was
undertaken within collaborating centres under the supervision of
the local responsible cardiologist; the names and addresses of the
children were not provided to the central study team who carried
out analyses on de-identified data.
Methods
The UKCSCHD includes children with serious CHDs born
between 1992 and 1995 and prospectively notified to a UK-wide
study evaluating fetal diagnosis by paediatric cardiologists (British
Congenital Cardiac Association [BCCA] members) in all 17 UK
paediatric cardiac surgical centres [13]. Serious CHDs were
defined as structural heart malformations requiring intervention or
resulting in death during the first year of life [13].
A retrospective hospital records review of 3897 children was co-
ordinated by the central research team; 268 children from the
original register were excluded as there were insufficient details in
the case notes to confirm that all inclusion criteria (Table 1) for the
UKCSCHD were met. Local clinicians extracted data and
completed a standardised proforma for 3698 (95%) of 3897
children. Record retrieval varied by centre, reflecting local record-
keeping, and retrieval was less successful for children who were
reported by local clinicians to have died (difference 6% [95% CI
4%, 8%]).
Deaths were traced within hospital systems then validated
through the Office for National Statistics (England and Wales) and
General Register Office (Scotland). A primary cardiac diagnosis
(Table 2) was assigned to every child using a hierarchical
classification prioritising the most severe structural defect adapted
from Wren et al. [14]; three clinical raters (CB, CW, RK)
independently assigned diagnoses (generalised kappa (k) for rater
agreement = 0.83) and the final diagnosis was agreed by consensus.
Two cardiologists (CB, CW) designated one procedure for each
child as ‘definitive’, defined as the procedure which would
approximate normal anatomy and restore biventricular function
or provide long-term palliation without expectation of further
surgery during childhood, thus the final stage of a multi-stage
repair was considered definitive. The definitive procedure may
have taken place at any time during follow-up. Children were
assigned to a cardiac prognostic severity (CPS) group, adapted
from Lane [15], based on primary diagnosis and whether their
definitive procedure was presumed curative, corrective or pallia-
tive (Table 2).
Statistical analysis
Descriptive statistics are presented as numbers and percentages,
or median and interquartile ranges (IQR), and 95% confidence
intervals (CI) were estimated for the difference between two
proportions. Table 3 provides information about the numbers of
children who died or were censored alive (last seen) during each
Table 1. Inclusion and exclusion criteria for the UKCSCHD cohort.
Inclusion criteria (for the UKCSCHD and original register). Live born infants:
1) born between 1st January 1992 and 31st December 1995
2) resident in the United Kingdom (UK) at birth
3) with a serious congenital heart defect, defined as a structural malformation of the heart or great vessels, requiring an intervention or resulting in death during the first
year of life.
Exclusion criteria (for the UKCSCHD and original register). Live born infants with:
1) isolated cardiovascular defects such as persistent ductus arteriosus, vascular ring or anomalous coronary arteries
2) myocardial dysfunction, arrhythmia or tumours in a structurally normal heart
3) a congenital heart defect that did not require an intervention or result in death during the first year of life.
Excluded from the UKCSCHD but included in the original register:
Babies with a fetal diagnosis of serious congenital heart defect made at prenatal ultrasound but not subsequently live born.
doi:10.1371/journal.pone.0106806.t001
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year of follow-up. The Kaplan-Meier survival function was
estimated up to 15 years of age; five children, whose date of
death was not known, were censored alive on the date of the last
hospital visit.
A multilevel discrete time event history model was developed to
investigate the factors influencing survival; this was a binomial logit
model with the response variable, death or censoring, coded as a
binary variable. The discrete time hazard function represented the
conditional probability of an event in each interval given that the
event had not occurred in a previous interval: h(t) = Pr(T= t | T$t).
The period of observation was divided into 24 discrete intervals; 12
intervals of one month duration for the first year of life when the
majority of events occurred, then 11 intervals of one year from one
to 12 years of age and a final interval of three years duration
representing the interval 12 to 15 years of age, in which events were
rare. In the final model including multiple predictors, three
‘smoothed’ categories (representing the first year of life, one to 12
years, and 12 to 15 years of age) were developed by estimating the
log-transformed midpoint of each variable and dividing by the
number of months within each category. Although the 24 category
model had marginally better fit than the ‘smoothed’ category model
(DIC 8887.9 and 8946.8 respectively), the smoothed category model
improved model convergence and was therefore used.
Within each interval, it was assumed that the hazards were
constant and the binary response variable indicated whether death
occurred during the final interval. Covariates specific to the child,
such as sex or preterm birth, remained constant whilst factors
recorded at each procedure, such as cardiopulmonary bypass
duration, were permitted to vary between intervals. Weight and
height were converted to age- and sex-standardised z-scores
(British 1990 growth reference) [16]. Each predictor was explored
in univariable analyses then multivariable models were construct-
ed to determine joint associations.
Missing data were imputed using a hierarchical imputation
model developed with MLwiN 2.18–2.20 [17] and Realcom-
Impute [18]. The imputation procedure used Markov-chain
Monte Carlo (MCMC) procedure to generate 20 imputed datasets
during 2500 iterations. Imputation was conditioned on centre
availability of records, as this significantly influenced missingness.
Imputation excluded 28 children whose date of death or censoring
was unknown, and variables with more than 50% missing data; the
included variable with the most missing data was clinical status on
admission (46%; Table 4). Distributions of continuous variables
before and after imputation were compared using density plots
(data not shown).
Hierarchical models of mortality risk were developed to take
account of the grouping of individual children within cardiac
centres and the correlation of procedure-related data within the
individual child. For each imputed dataset multilevel discrete-time
event models [19,20] were constructed to predict mortality risk
from birth to follow-up in 2007, when all surviving children were
aged 12 to 15 years. The final results reported are those averaged
over these datasets according to ‘Rubin’s rules’. The results from
these analyses using imputed datasets were compared with those
using the ‘complete case’ datasets (including only those children
with complete data).
Analyses were undertaken using Stata SE 11 (Timberlake
Consulting) and MLwiN 2.18–2.20 [17].
Results
Almost one-quarter of the cohort died (n = 932 deaths) and, of
these, 727 (78%) deaths occurred within the first year and 323
(35%) within the first month of life. Although the risk of death was
lower after the first year of life, 20% of all cohort deaths occurred
after one year of age. Death occurred before intervention, or
parents chose palliative care, for 144 (4%) children who died
without any procedure; most (n = 63; 44%) of these children had
hypoplastic left heart and/or mitral atresia (HLH/MA). The
median age at death for children who died without undergoing an
Table 3. Number of children dying or last seen (censored) during each year of follow-up.
Year of follow-up Number at risk Deaths Censored (last seen)
(from birth = 0) n n n
0–1 year 3897 727 681
1–2 years 2489 78 103
2–3 years 2308 35 55
3–4 years 2218 28 46
4–5 years 2144 16 58
5–6 years 2070 11 53
6–7 years 2006 8 48
7–8 years 1950 8 64
8–9 years 1878 3 106
9–10 years 1769 5 168
10–11 years 1596 4 405
11–12 years 1187 4 520
12–13 years* 663 4 424
13–14 years* 235 1 214
14–15 years* 20 0 20
*All children in the cohort were aged 12 years or older at the time of ascertainment of deaths in 2007, thus losses from follow-up at younger ages were due to death or
censoring alive on the date last seen (as recorded in hospital case notes). Between 12 and 15 years there are fewer children under follow-up (‘at risk’) in the older age
groups as many children had not reached these ages and this reduced the precision of survival estimates after 12 years.
doi:10.1371/journal.pone.0106806.t003
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intervention was 8.5 days (IQR 3, 75.5 days) and only one-third
survived beyond the first month of life. Of 723 children who
survived to one year without having undergone a definitive
corrective or palliative procedure, 578 (80%) died between age one
and 15 years. There was no significant difference in the proportion
of girls and boys who died without a procedure. Characteristics of
the cohort children and procedure-related factors are presented in
Table 5 and Table 6 respectively.
Overall 80% (95% CI 78%–81%) of children were alive at one
year and 72% [70%, 73%] at 15 years of age. Survival varied by
primary cardiac diagnosis (Figure 1; Table 7). For 2,489 children
remaining under follow-up after one year of age, survival between
one and 15 years was 90% (95% CI 88%, 91%) overall, however
for children within six diagnostic subgroups (HLH/MA, tricuspid
atresia [TA], double inlet ventricle [DIV], pulmonary atresia with
intact ventricular septum [PA+IVS], PA+VSD and CAVSD),
survival post-infancy was lower than 90%.
In univariable models involving all children followed from birth,
preterm birth (hazard ratio [HR] 1.43 [95% CI: 1.16, 1.77]), non-
Down’s syndrome non-cardiac malformations (HR 1.56 [1.27,
1.93]), cardiac defects additional to the primary diagnosis (HR
1.24 [1.09, 1.41]) and unstable clinical status on first admission
(HR 1.43 [1.07, 1.90]) were statistically significant predictors of
higher mortality. Relative to the largest subgroup (ventricular
septal defect [VSD]), all primary diagnostic subgroups except
pulmonary stenosis (PS) and aortic coarctation (COA) were
associated with increased mortality.
In the multivariable model including all children and adjusted
for centre effects, higher mortality up to age 15 years was
associated with female sex (HR 1.25 [1.06, 1.47]), preterm birth
(HR 1.44 [1.15, 1.79]), non-Down’s syndrome non-cardiac
malformations (HR 1.49 [1.20, 1.86]), additional cardiac defects
(HR 1.23 [1.07, 1.42]) and, relative to VSD, all primary diagnoses
except for PS and COA (data not shown). When procedure-related
risk factors were included in the multivariable model, thus
excluding children who died without a procedure, independent
predictors of higher mortality risk were female sex, preterm birth,
additional cardiac defects, pre-procedure sepsis or hypertension,
post-procedure seizures, cardiac arrest, renal failure, stroke, sepsis
or disseminated intravascular coagulopathy (DIC), lower weight or
Table 5. Characteristics of individuals in the cohort (n = 3897).
Patient-specific factors N (% of 3897) Missing
N (% of 3897)
Sex 129 (3%)
Boys 2147 (55%)
Girls 1621 (42%)
Preterm birth 0
Gestation ,37 weeks 296 (8%)
Gestation $37 weeks 3601 (92%)
Non-cardiac malformations 0
Down’s syndrome (DS) 293 (8%)
Non-DS non-cardiac malformations 290 (7%)
No non-cardiac malformations 3314 (85%)
Additional cardiac defects 0
Isolated CHD 1826 (47%)
Additional cardiac defects 1488 (53%)
Antenatal diagnosis of CHD 0
Antenatal diagnosis 177 (5%)
Postnatal diagnosis 3720 (95%)
Factors related to management
Clinical status on first admission 1784 (46%)
Stable 953 (24%)
Unstable 1160 (30%)
Age at first procedure (median [IQR]) 38 (6, 121) days
Weight z-score at first procedure (median [IQR]) 21.7 (IQR 22.83, 20.58)
Height z-score at first procedure (median [IQR]) 20.8 (IQR 22.03, 0.42)
Number of procedures (median [IQR]) 1 (1, 2)
Notes:
IQR interquartile range;
Preterm birth - before 37 completed weeks of gestation;
Additional cardiac defects - children who had at least one structural cardiac defect in addition to their primary cardiac diagnosis;
Non-Down’s syndrome non-cardiac malformations - a further 290 children had non-cardiac congenital malformations that were not Down’s syndrome, including
recognised syndromes such as Di George’s (n = 61).
Clinical status on first admission was defined as unstable if one or more of the following symptoms/signs were present: unwell = significant pallor, breathlessness or
sweating, intubated, mechanically ventilated, hypotension = systolic blood pressure [SBP] ,50 mmHg, hypertensive = SBP .100 mmHg, cardiac or respiratory arrest,
metabolic acidosis, requiring adrenaline or high dose inotropic support.
doi:10.1371/journal.pone.0106806.t005
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height z-score, younger age at first procedure, or longer duration
of cardiopulmonary bypass or cardiac arrest (Table 8). Non-
Down’s syndrome non-cardiac malformation and postoperative
ECMO were not significant predictors of higher mortality.
Mortality risk for children with TGA and COA was similar to
VSD, and significantly higher than VSD for all other CHD
subgroups.
In sensitivity analyses results from the imputed models were
compared with those using complete cases; the imputed data
analyses provided greater precision with no significant difference
in the magnitude and direction of effect. During stepwise
development of the model, the variable representing definitive
surgery did not significantly improve the model and was excluded.
However in a sensitivity analysis involving only 606 children who
had complete data and were alive at age one year, mortality risk
was significantly lower for those who had experienced definitive
surgery by age one year than for those who did not (HR 0.19,
95%CI 0.05, 0.73; p = 0.015).
Discussion
In this UK-wide cohort involving 3897 children with serious
CHDs, mortality was 20% in the first year of life. An additional
8% of the cohort died between one and 15 years of age, thus 20%
of all deaths within the cohort occurred after the first year of life.
There were 144 children in the cohort who died without any
intervention during the first year of life. Overall survival was
79.8% at one year and 71.7% at 15 years of age with variation by
primary cardiac diagnosis, thus for children who survived the first
year survival into adulthood was generally good. Children with
functional single ventricles (HLH/MA, TA and DIV) experienced
the highest mortality overall but for children surviving to one year
of age, those with PA+VSD and CAVSD had the worst post-infant
survival rates.
Primary cardiac diagnosis was an important independent
predictor of mortality risk up to 15 years; children with TGA,
COA and VSD had the lowest mortality risk. Higher mortality risk
regardless of intervention was independently associated with
female sex, preterm birth and having a cardiac defect in addition
to the primary cardiac diagnosis. For children who had at least one
procedure, higher mortality risk was associated with earlier age at
Table 6. Characteristics of procedure-related factors (6351 procedures in 3753 individuals).
Procedure-related factors Details of procedures
N (% of 6351 procedures)
Pre-procedure variables:
Any pre-procedure complications/support 786 (12%)*
Intubated 590
Inotropic support 252
Acidosis 159
Hypotensive (systolic BP ,50 mmHg) 111
Sepsis 93
Hypertensive (systolic BP .100 mmHg) 51
Seizures 46
Intra-procedure variables:
Procedures not requiring bypass` 2486 (39%)
Cardiopulmonary bypass (CPB) time{ 2346 median = 87(IQR 60,129) minutes
Circulatory arrest (CA) time{ 1059 median = 30 (IQR 14,49) minutes
Aortic cross-clamp (XC) time{ 1980 median = 52 (IQR 32,75) minutes
Post-procedure variables:
Any post-procedure complications 816 (13%)*
Sepsis 356
Re-intubated (after 24 hrs extubation) 224
Renal failure 202
Cardiac arrest 169
Seizures 113
ECMO (extracorporeal membrane oxygenation) 47
DIC (disseminated intravascular coagulopathy) 31
Stroke 22
Notes:
IQR interquartile range; BP blood pressure; hrs hours.
*Procedures at which there was more than one pre-procedure (or post-procedure) complication are only counted once in the totals so the sum of individual
complications is greater.
`Procedures for which cardiopulmonary bypass would not be required, e.g. catheter intervention.
{Excludes procedures in which duration is recorded as 0 minutes.
doi:10.1371/journal.pone.0106806.t006
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first procedure, pre-procedural sepsis and hypertension (systolic
BP.100 mHg), post-procedural complications (including cardiac
arrest, stroke, renal failure, seizures and sepsis) and increased
duration of cardiopulmonary bypass or cardiac arrest.
Longitudinal cohort studies present important methodological
challenges for survival analysis, including the need to model
hierarchical data structures, repeated procedures, and to address
missing data. An important strength of our study is the
development of multilevel models that allowed us to link
procedure-related factors across the child’s lifecourse and to
explicitly order these in time. Children in the cohort underwent
varying numbers of procedures, which did not occur at fixed ages,
and earlier postoperative experience could influence later man-
agement. Despite recognition of the complexity of survival analysis
in children with CHDs, for whom both predictors and mortality
are time-dependent [11], examples of survival models including
time-varying covariates are rare and few previous studies have
explicitly stated the temporal ordering of childhood factors and
their inter-relationships, directly or through mediating factors,
with mortality. We addressed the methodological challenges of
repeat observations, and also adjusted for the effects of clustering
by cardiac centre, through the development of discrete-time
hierarchical survival models [19,20] and multilevel multiple
imputation [44,45] of missing values. The use of imputed datasets,
by allowing us to include all cohort children and procedures in the
analyses, reduced the likelihood of bias that can result from
restricting analyses to the small proportion of children with
complete data [21]. Our sensitivity analyses evaluating the effect of
multiple imputation in comparison with complete-case datasets,
demonstrated that imputed data contributed to greater precision
in mortality estimates and ensured that the impact of less
Figure 1. Survival from birth to 15 years by primary diagnosis (for individual diagnoses). Notes: Interrupted vertical lines represent
survival at 1 and 12 years. The survival curve for all children within the cohort is represented by a dotted line. The survival curve for children with
each specific cardiac diagnosis is represented by a solid line. Abbreviations: HLH/MA hypoplastic left heart and/or mitral atresia; TA tricuspid
atresia; DIV double inlet ventricle; PA+IVS pulmonary atresia with intact ventricular septum; PA+VSD pulmonary atresia with ventricular septal
defect; CAT common arterial trunk; CAVSD complete atrioventricular septal defect; TGA transposition of the great arteries; TOF tetralogy of Fallot;
TAPVC total anomalous pulmonary venous connection; VSD ventricular septal defect; AS aortic stenosis; PS pulmonary stenosis; COA coarctation
of the aorta; Misc miscellaneous cardiac defects.
doi:10.1371/journal.pone.0106806.g001
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commonly reported factors, such as pre- and post-procedural
complications, was quantifiable.
Although we were prevented by our governance permissions
[22] from accessing routine mortality data to check for deaths
amongst children who clinicians presumed to be surviving, all
reported deaths were confirmed against public death registrations.
As children with serious CHDs remain under review throughout
life, we believe that our ascertainment of deaths through
cardiologists, hospital records and GPs was complete.
The heterogeneity of CHDs also presents a significant problem
for population-based analyses [23,24] and variability in classifica-
tion systems often limits comparisons between studies. Our simple
hierarchical classification adapted from Wren [14] and validated
on data available from medical case notes, ensured that each child
was assigned to only one CHD subgroup and avoided double-
counting of children with multiple cardiac defects. As similar
classifications have been successfully applied in other UK studies
[9,25] [26], this provides a sound basis for cross-study compar-
isons.
Patients do not pay for care within the UK healthcare system,
thus there were no financial barrier to accessing surgery and
deaths in children who were offered only palliative medical care
were related to the inoperability of the defect. As with all long-
term follow-up, early management of cohort members who were
born in 1992–1995 was determined by clinical era. Although our
cohort has its inception after the introduction of neonatal cardiac
surgery and key procedures, such as the arterial switch operation,
paediatric cardiac surgical and intensive care technologies have
continued to advance, notably for children with HLH for whom
Norwood-type surgery is now widely available, or with TOF for
whom neonatal surgery is now common. Nonetheless, surgical
management has not altered markedly for many CHD subgroups.
Advances in fetal screening s well as surgery may also alter the
proportion of children who would be offered palliative medical
care in current practice compared our cohort. Whereas fetal
screening detected around 23% of severe CHDs in 1993–94 [13],
this has now increased to detection of around one-third of cases
[27], which may mean that more children born today would
commence specialist care at birth than in our cohort. The findings
from our cohort should therefore be interpreted with caution
within specific diagnostic subgroups where surgical techniques or
screening detection have altered significantly as there may be
improved survival for children born today. Nevertheless we believe
our results are still likely to remain relevant overall to children
born and operated with CHDs today, particularly for diagnostic
subgroups in which significant improvements in early postopera-
tive survival have not been seen.
There are relatively few population-based observational cohort
studies that describe mortality and survival up to age 12–15 years
for children affected by CHDs (Table 9). Although we also present
some findings from our model including children who remained
unoperated at the time of death, the majority of these children
died in the first month after birth, many had HLH and palliative
care was chosen by some parents; management of such severe and
complex cases has continued to advance in the last decade. Thus
our main model excludes these unoperated cases and focuses on
survival from birth for the majority of children in the cohort, who
did undergo an intervention.
Reviewing all child CHD deaths in Bohemia between 1952 and
1979, Samanek reported that ‘natural’ survival before the
widespread introduction of paediatric cardiac surgery was 67%
at 15 years [28]. Three further studies investigated survival in large
surgical cohorts [10,29,30], including a Finnish population-based
study between 1953 and 1989 in which survival was reported as
78% at 45 years after surgery, significantly lower than for the
unaffected population. Only three studies have reported survival
after diagnosis in early life, including children who remained
unoperated as well as those undergoing surgery, of which two
present directly observed survival from diagnosis [31] [32]. These
two studies, representing contemporary management, document-
ed better overall survival (Table 10) than we observed but up to
40% of children survived without any interventions suggesting
Table 7. Data Table for Figure 1.
PRIMARY CARDIAC DIAGNOSIS Number at birth Survivor function
(95% confidence intervals)
n At 1 year At 12 years
Hypoplastic left heart/mitral atresia 199 28%(22%,35%) 21%(15%,27%)
Tricuspid atresia 67 74%(62%,83%) 61%(48%,72%)
Double inlet ventricle 85 72%(61%,80%) 62%(50%,71%)
Pulmonary atresia with intact ventricular septum 83 73%(62%,82%) 65%(53%,74%)
Pulmonary atresia with ventricular septal defect 151 84%(77%,89%) 60%(51%,68%)
Common arterial trunk (truncus arteriosus) 99 55%(44%,64%) 51%(40%,61%)
Complete atrioventricular septal defect 460 71%(67%,76%) 57%(52%,62%)
Transposition of the great arteries 597 85%(82%,88%) 81%(77%,84%)
Tetralogy of Fallot 361 85%(81%,88%) 79%(74%,83%)
Total anomalous pulmonary venous connection 150 71%(62%,78%) 71%(62%,78%)
Ventricular septal defect 760 90%(87%,92%) 86%(83%,88%)
Aortic stenosis 107 81%(72%,87%) 78%(69%,85%)
Pulmonary stenosis 194 91%(85%,94%) 89%(83%,93%)
Coarctation of the aorta 395 94%(90%,96%) 90%(86%,93%)
Miscellaneous 189 77%(70%,83%) 68%(60%,75%)
doi:10.1371/journal.pone.0106806.t007
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that, in comparison with the UKCSCHD, they included a higher
proportion of mild CHDs that were compatible with survival
without intervention.
Surgical case series have highlighted important associations
between increased postoperative mortality risk and factors such as
low birth weight [33,34], preterm birth [35], sudden clinical
deterioration in the neonatal period [36,37], and procedure-
associated complications, including sepsis and renal failure [38].
Several studies have demonstrated the detrimental impact of
longer intra-procedure duration of cardiopulmonary bypass and
cardiac arrest [39–42], also observed in our cohort, although most
previous authors estimated the effect at a single procedure only
rather than repeated exposure over multiple procedures. More-
over Kang has cautioned that longer duration of cardiopulmonary
bypass may only reflect technically more difficult surgery [41].
Although our findings indicate that girls with CHDs are at
significantly higher risk of death, published evidence for sex
differences in mortality for individuals with CHDs remains
inconclusive. Morris [29] demonstrated that girls with COA and
TGA had higher mortality prior to intervention, whereas Fyler
[43] reported a higher death rate for boys during the first year of
life. Other authors have highlighted that girls experience higher
perioperative mortality related to paediatric cardiac surgery [44–
47]. As the ratio of boys to girls affected varies by specific cardiac
defect, these sex differences may be confounded by the severity of
cardiac diagnosis. Nevertheless children’s cardiac size and
function, lung development and immune responses have been
shown to vary by sex [47–51], therefore biological differences also
provide a plausible explanation for sex differences in mortality risk
and would merit further research.
In accordance with previous reports [52,53], we found no
independent influence on mortality associated with Down’s
syndrome. Eskedal [52] has highlighted that children with CHDs
who have non-cardiac malformations other than Down’s syn-
drome experience higher mortality than those with isolated
cardiac defects. In our cohort, non-Down’s non-cardiac malfor-
mations were significant predictors of mortality when children who
died without intervention were included in the analysis, suggesting
that these malformations do contribute to mortality in this
subgroup.
It is now over a decade since the Bristol Inquiry addressed
concerns about the care of children receiving cardiac surgery at
the Bristol Royal Infirmary [54]. Expert evidence presented to the
Inquiry emphasised the lack of data on long-term outcomes
relevant to children and their families [55]. The Central Cardiac
Audit Database (CCAD) now routinely collects national outcome
data for cardiac procedures, including survival up to one year after
paediatric cardiac intervention; these data are published through
the National Institute for Cardiac Outcomes Research (NICOR)
Congenital Heart Disease Portal [56].
While routine audit remains essential to monitoring outcomes
for children receiving interventions for CHDs in the UK [57], a
procedure-based system excludes children who never receive an
intervention and often fails to capture late mortality and broader
health outcomes, such as educational achievement or quality of
life. Improved record linkage between multiple routinely collected
data sources, supplemented by focused observational or clinical
studies, could enrich current routine data collection and provide
more efficient use of existing resources for extended follow-up.
Conclusions
The UKCSCHD has provided a unique opportunity to observe
survival and wider health outcomes throughout childhood in a
prospectively ascertained UK-wide cohort that is largely repre-
sentative of contemporary management. We found that infant
mortality under age one year for children with serious CHDs was
over 30 times greater than for the general population, estimated at
six per 1,000 live births [58]. It is also clear from our data that
whilst children with CHDs were still most likely to die in infancy in
this cohort, over 20% of CHD-related deaths in childhood took
place after the first year of life. Surgical management of serious
Table 10. Childhood survival by primary cardiac diagnosis reported within population-based cohort studies published since 1990.
PRIMARY CARDIAC DIAGNOSIS UKCSCHD
Samanek, 1992
[28] Meberg, 2000 [31] Wren, 2001 [9]
At age 12 years
(‘observed’)
At age 15 years
(‘natural’)*
At age 9.5 years
(‘observed’)
At age 15 years
(‘predicted’)1
Hypoplastic left heart 21% 11% 22% 0
Pulmonary atresia 60–65% 30% 75% 40%
Common arterial trunk (truncus arteriosus) 51% 11% 50% 31%
Complete atrioventricular septal defect 57% 49% 55% 55%
Transposition of the great arteries 81% 38% 85% 67%
Tetralogy of Fallot 79% 86% 82% 84%
Total anomalous pulmonary venous connection 71% 0 - 70%
Ventricular septal defect 86% 76% 97% 91%
Aortic stenosis 78% 84% 92% 66%
Pulmonary stenosis 89% 94% 93% 92%
Coarctation of the aorta 90% 68% 84% 85%
Notes:
This table compares defect-specific survival reported in childhood within four population-based cohorts that include all children diagnosed in infancy even if no
intervention was performed. Most studies present ‘observed’ cohort survival from diagnosis or first surgery during infancy, with the exception of:
*Samanek presents ‘natural’ survival in an era prior to widespread surgical correction.
1Wren presents ‘predicted’ survival up to age 15 years based on observed survival to age 1 year and survival from 1 to 15 years estimated from a review of the published
literature.
doi:10.1371/journal.pone.0106806.t010
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CHDs carries an initial perioperative risk of death or neurological
injury in childhood, but the altered physiology of the operated
heart may also result in reduced ability to cope with ageing or
cardiac stressors arising in adult life. Long-term survival and
health outcomes are influenced by health events across the
lifecourse thus optimising the health experience of preschool and
school-age children with CHDs is as relevant to future improve-
ments in survival and quality of life of adults with CHDs as
successful early surgical repair. Crucially cardiac diagnosis
remained an important predictor of outcome particularly as this
influenced the type of definitive procedure, whether this was
palliative or corrective, and the age at which it was performed.
However, we also identified procedure-related predictors of
mortality that may be amenable to modification in order to effect
further advances in survival or improve health outcomes after
surgery. Investigation into the biological mechanisms contributing
to higher mortality for girls is warranted to explore the potential
for improving future outcomes and reducing health inequalities.
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